These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
416 related articles for article (PubMed ID: 29883490)
61. Genomic Insights into Two Colistin-Resistant Yap PSX; Ahmad Kamar A; Chong CW; Ngoi ST; Teh CSJ Microb Drug Resist; 2020 Mar; 26(3):190-203. PubMed ID: 31545116 [No Abstract] [Full Text] [Related]
62. Genetic Characterisation of Colistin Resistant Singh S; Pathak A; Rahman M; Singh A; Nag S; Sahu C; Prasad KN Front Cell Infect Microbiol; 2021; 11():666030. PubMed ID: 34235092 [TBL] [Abstract][Full Text] [Related]
63. Whole Genome-Based Characterization of Multidrug Resistant Enterobacter and Klebsiella aerogenes Isolates from Lebanon. Merhi G; Amayri S; Bitar I; Araj GF; Tokajian S Microbiol Spectr; 2023 Feb; 11(1):e0291722. PubMed ID: 36651778 [TBL] [Abstract][Full Text] [Related]
64. Molecular epidemiology of carbapenem resistant Enterobacteriaceae in Valle d'Aosta region, Italy, shows the emergence of KPC-2 producing Klebsiella pneumoniae clonal complex 101 (ST101 and ST1789). Del Franco M; Paone L; Novati R; Giacomazzi CG; Bagattini M; Galotto C; Montanera PG; Triassi M; Zarrilli R BMC Microbiol; 2015 Nov; 15(1):260. PubMed ID: 26552763 [TBL] [Abstract][Full Text] [Related]
65. Rapid Increase in Prevalence of Carbapenem-Resistant Enterobacteriaceae (CRE) and Emergence of Colistin Resistance Gene Li Y; Sun QL; Shen Y; Zhang Y; Yang JW; Shu LB; Zhou HW; Wang Y; Wang B; Zhang R; Wang S; Shen Z J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29386265 [TBL] [Abstract][Full Text] [Related]
66. The determination of gyrA and parC mutations and the prevalence of plasmid-mediated quinolone resistance genes in carbapenem resistant Klebsiella pneumonia ST11 and ST76 strains isolated from patients in Heilongjiang Province, China. Zeng L; Zhang J; Li C; Fu Y; Zhao Y; Wang Y; Zhao J; Guo Y; Zhang X Infect Genet Evol; 2020 Aug; 82():104319. PubMed ID: 32278145 [TBL] [Abstract][Full Text] [Related]
67. OXA-181-Like Carbapenemases in Klebsiella pneumoniae ST14, ST15, ST23, ST48, and ST231 from Septicemic Neonates: Coexistence with NDM-5, Resistome, Transmissibility, and Genome Diversity. Naha S; Sands K; Mukherjee S; Saha B; Dutta S; Basu S mSphere; 2021 Jan; 6(1):. PubMed ID: 33441403 [TBL] [Abstract][Full Text] [Related]
68. Genomic Analysis of a Pan-Resistant Isolate of de Man TJB; Lutgring JD; Lonsway DR; Anderson KF; Kiehlbauch JA; Chen L; Walters MS; Sjölund-Karlsson M; Rasheed JK; Kallen A; Halpin AL mBio; 2018 Apr; 9(2):. PubMed ID: 29615503 [TBL] [Abstract][Full Text] [Related]
70. Tracking short-term changes in the genetic diversity and antimicrobial resistance of OXA-232-producing Klebsiella pneumoniae ST14 in clinical settings. Kim YJ; Kim S; Kim J; Bae S Clin Microbiol Infect; 2020 Jan; 26(1):78-86. PubMed ID: 31128287 [TBL] [Abstract][Full Text] [Related]
71. Molecular and epidemiological surveillance of polymyxin-resistant Klebsiella pneumoniae strains isolated from Brazil with multiple mgrB gene mutations. da Silva KE; Thi Nguyen TN; Boinett CJ; Baker S; Simionatto S Int J Med Microbiol; 2020 Oct; 310(7):151448. PubMed ID: 33092694 [TBL] [Abstract][Full Text] [Related]
72. Clonal emergence of Klebsiella pneumoniae ST14 co-producing OXA-48-type and NDM carbapenemases with high rate of colistin resistance in Dubai, United Arab Emirates. Moubareck CA; Mouftah SF; Pál T; Ghazawi A; Halat DH; Nabi A; AlSharhan MA; AlDeesi ZO; Peters CC; Celiloglu H; Sannegowda M; Sarkis DK; Sonnevend Á Int J Antimicrob Agents; 2018 Jul; 52(1):90-95. PubMed ID: 29530587 [TBL] [Abstract][Full Text] [Related]
73. Worldwide emergence of colistin resistance in Klebsiella pneumoniae from healthy humans and patients in Lao PDR, Thailand, Israel, Nigeria and France owing to inactivation of the PhoP/PhoQ regulator mgrB: an epidemiological and molecular study. Olaitan AO; Diene SM; Kempf M; Berrazeg M; Bakour S; Gupta SK; Thongmalayvong B; Akkhavong K; Somphavong S; Paboriboune P; Chaisiri K; Komalamisra C; Adelowo OO; Fagade OE; Banjo OA; Oke AJ; Adler A; Assous MV; Morand S; Raoult D; Rolain JM Int J Antimicrob Agents; 2014 Dec; 44(6):500-7. PubMed ID: 25264127 [TBL] [Abstract][Full Text] [Related]
77. Clinical and Molecular Description of a High-Copy IncQ1 KPC-2 Plasmid Harbored by the International ST15 Klebsiella pneumoniae Clone. Martins WMBS; Nicolas MF; Yu Y; Li M; Dantas P; Sands K; Portal E; Almeida LGP; Vasconcelos ATR; Medeiros EA; Toleman MA; Walsh TR; Gales AC; Andrey DO mSphere; 2020 Oct; 5(5):. PubMed ID: 33028683 [TBL] [Abstract][Full Text] [Related]
78. Emergence and dissemination of colistin-resistant Klebsiella pneumoniae isolates expressing OXA-48 plus CTX-M-15 in patients not previously treated with colistin in a Spanish university hospital. Barragán-Prada H; Ruiz-Hueso P; Tedim AP; González-Candelas F; Galán JC; Cantón R; Morosini MI Diagn Microbiol Infect Dis; 2019 Feb; 93(2):147-153. PubMed ID: 30266401 [TBL] [Abstract][Full Text] [Related]
79. Isolation, characterization, therapeutic potency, and genomic analysis of a novel bacteriophage vB_KshKPC-M against carbapenemase-producing Klebsiella pneumoniae strains (CRKP) isolated from Ventilator-associated pneumoniae (VAP) infection of COVID-19 patients. Mohammadi M; Saffari M; Siadat SD; Hejazi SH; Shayestehpour M; Motallebi M; Eidi M Ann Clin Microbiol Antimicrob; 2023 Feb; 22(1):18. PubMed ID: 36829156 [TBL] [Abstract][Full Text] [Related]
80. Colistin resistance due to insertional inactivation of the mgrB in Klebsiella pneumoniae of clinical origin: First report from India. Kumar A; Biswas L; Omgy N; Mohan K; Vinod V; Sajeev A; Nair P; Singh S; Biswas R Rev Esp Quimioter; 2018 Oct; 31(5):406-410. PubMed ID: 30221899 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]